- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07711535
Development of Context-Adapted Quality Indicators for Early Sepsis Care in Sub-Saharan Africa - A Modified Delphi Consensus Procedure
Studieoversigt
Status
Betingelser
Detaljeret beskrivelse
The expert panel will be recruited through purposive sampling via existing national and international sepsis networks (including the Sub-Saharan African Consortium for the Advancement of Innovative Research and Care in Africa, "STAIRS"), scientific collaborations, and personal invitations from the study team in Berlin.
Invited are professionals with proven experience in sepsis care or sepsis research in sub-Saharan Africa, including physicians, nurses, researchers, and other healthcare professionals involved in acute care and quality assurance.
For the first Delphi round, the investigators plan to recruit approximately 10-15 experts. In a second recruitment phase, participants may nominate additional experts with relevant expertise (snowball sampling). The total number of panel members should not exceed 30-45.
Undersøgelsestype
Tilmelding (Anslået)
Kontakter og lokationer
Studiekontakt
- Navn: Claudia Spies, MD, Prof.
- Telefonnummer: +49 30 450 55 11 02
- E-mail: claudia.spies@charite.de
Studiesteder
-
-
-
Kumasi, Ghana
- Rekruttering
- The Komfo Anokye teaching hospital
-
Kontakt:
- Telefonnummer: +233 593 830 400
- E-mail: info@kath.gov.gh
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Prøveudtagningsmetode
Studiebefolkning
Beskrivelse
Inclusion Criteria:
- Professionals with proven experience in sepsis care or sepsis research in low- and middle-income countries, particularly Sub-Saharan Africa including physicians, nurses, researchers, and other healthcare professionals involved in early acute care and quality assurance
- Minimum age of 18
- Willingness to voluntarily participate in one or more Delphi rounds
Exclusion criteria:
- Lack of professional expertise in the field of sepsis care
- Refusal to consent to participation
- Withdrawal from participation at the participant's own request
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
The degree of expert consensus on individual quality indicators
Tidsramme: Up to October 2026
|
The degree of expert consensus on individual quality indicators, measured on a 5-point Likert scale (median and interquartile range) .
|
Up to October 2026
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
The final, agreed-upon set of quality indicators
Tidsramme: Up to October 2026
|
The final, agreed-upon set of quality indicators is developed during the project
|
Up to October 2026
|
|
The agreed-upon structure of the STEPS survey instrument.
Tidsramme: Up to October 2026
|
The agreed-upon structure of the STEPS survey instrument.
|
Up to October 2026
|
|
The agreed-upon content of the STEPS survey instrument.
Tidsramme: Up to October 2026
|
The agreed-upon content of the STEPS survey instrument.
|
Up to October 2026
|
Samarbejdspartnere og efterforskere
Efterforskere
- Studieleder: Claudia Spies, MD, Prof., Charite University, Berlin, Germany
Datoer for undersøgelser
Studer store datoer
Studiestart (Anslået)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- Delphi-QI-Steps
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .